We have recently encountered a situation where patients are able to purchase keys compatible with the Alaris pumps through eBay or Amazon and bring them into the inpatient setting. While we can work on a process to control purchasing these keys as the replacements for the institution, what measures have you implemented to prevent a patient from using a self-procured key inappropriately?

Apparently Lomotil liquid oral susp is being discontinued. Are facilities crushing the tablets in a CVE or using an alternative product?

https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-deta...

Hi, has anyone encountered issues with nursing units reporting under or over fills for infusion bags that are made to total volume? Specifically for onc infusion bags and/or peds?

Does anyone stock 10unit/10mL or 5unit/5mL insulin syringes in their ADC for nurse to remove and administer for IV push administration? We are a non-24hr pharmacy, so need something safe to provide for after hours. I would love to pre-prepare doses like this instead of having them pull out of a large vial. Any stability information would be very much appreciated. Thank you!!

We are building a new library for our conversion from an end of life Baxter to BBraun Infusomat and I'd like some tips about the use of categories.

Hello,

Anyone using DoseTrac and able to obtain data on hard limit alerts?

BBraun tells us it's not possible since in these instances we had to get out of the library to be able to program the pump.

We are new users of this software and find it hard to believe there is no way to get stats on this.

Thanks.

Serge

Like many institutions, our ED is autoverified. We do limit some orders through a "never autoverify" med list. The question has been raised about benefit of the orders still being autoverified to prevent a delay in administration, but having more orders in the pharmacist queue to review the autoverification. Looking to solicit feedback if anyone utilizes a hybrid approach such as this and how it was received.

Our EHR is Epic.

Thank you!
John Morgan

1. How does your institution handle teaching/transitions of care for patients being discharged on insulin pens? For example:

a. Are insulin pens available in the hospital pharmacy for teaching prior to discharge?
b. Are insulin demo pens available in the hospital for teaching prior to discharge?
c. Are insulin pens procured from outpatient/retail pharmacy (brown-bagged) for teaching prior to discharge?
d. Other (please explain)
e. None of the above

RE: Best practice 20, would greatly appreciate lessons learned from folks that have transitioned to primarily premixed Tranexamic acid bags in their peri-operative spaces.

Specifically, did you encounter any challenges related to tranexamic acid topical use? Did you leave vials available in a restricted manner? Any other helpful tips.

Thanks,
Paul

Hi,

We have a few questions regarding airway carts and neuromuscular blocker storage.
1. Does your organization have airway carts in perioperative areas?
2. Do your organization's airway carts contain medication, specifically neuromuscular blockers (NMB)?
3. If your airway carts contain NMB, how are they stored and monitored?

Thank you!
Gabriella Philipson, PharmD